2016 World Parkinson Congress Leadership Forum Before the 4th World Parkinson Congress officially kicked-off in Portland, Oregon nearly 200...see more
APDA Funded Researcher Published in Journal of Neuroscience – July 2016
APDA funded researcher published in Journal of Neuroscience – July 2016 APDA funded research demonstrates that alpha-synuclein inclusion formation...see more
ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) is now available
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis is now available...see more
FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin)
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with...see more
Gene Therapy Prevents Parkinson’s Disease in Animal Model, Says Pitt Study
PITTSBURGH, June 15, 2015 – Gene therapy to...see more
April Parkinson’s Awareness Month Proclamation
Assemblywoman Malliotakis presents a Proclamation announcing April as “Parkinson’s Disease Awareness Month” to Leslie...see more
APDA Partners with BioMech to Raise Funds and Get Golfers With PD Back into the Swing
APDA Partners with BioMech to Raise Funds and Get Golfers With Parkinson’s Disease Back into the Swing People with...see more
APDA Is Proud To Join Parkinson’s Action Network’s Unified Partners Program
(New York, NY, June 3, 2015) – The...see more
APDA official charity of Rite Aid Cleveland Marathon 2015
American Parkinson Disease Association official charity of Rite Aid Cleveland Marathon 2015 The Rite Aid Cleveland Marathon named the...see more
APDA Awards More Than 1.1 Million to Research
The American Parkinson Disease Association (APDA), has awarded more than $1.1 million in seven research grants, four post-graduate fellowships,...see more